Saturn V Capital Management LP

CIK

1964437

Location

AUSTIN, TX

Portfolio Value

Small $552,217,503

Diversification

Diversified

Filing Date

Global Rank

#2,173 / 8,232 ▲ 160

Top Industry

Biotechnology 89.1%

3Y Alpha vs SPY

+5.7%

Period ended 2 months ago

Filed May 15, 2026 · 29d

14 quarters · since Dec 2022

Clone Performance

Jun 2023–Jun 2026 · vs SPY

Hypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.

Cloned portfolio

+102.5%

SPY

+76.5%

Annualised alpha

+5.7%

Max drawdown

−45.1%

Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.

Portfolio Concentration

21 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025

Top Position

12.8%

−3.3 pts

Top 5

49.5%

+1.0 pts

Top 10

77.0%

+0.6 pts

HHI

734

Diversified−24

Portfolio Trend

14 quarters · across all stocks

Sector Breakdown

As of Mar 31, 2026

Sector	% Portfolio	Value	Positions
Healthcare	100.0%	$552,217,503	21

Last Quarter's Activity

Export CSV

Mar 31, 2026 vs Dec 31, 2025

Added To

Positions the filer increased

10 positions

Ticker	Company	Δ Shares	Shares	Value
IVVD	Invivyd, Inc.	+3,213,698	10,949,084	$14,233,809
OVID	Ovid Therapeutics Inc.	+1,666,666	4,166,666	$9,249,998
IMMX	Immix Biopharma, Inc.	+694,416	3,693,585	$33,648,559
XFOR	X4 Pharmaceuticals, Inc	+656,116	6,456,646	$26,665,947
IRON	Disc Medicine, Inc.	+151,497	449,926	$28,768,268
ALMS	Alumis Inc.	+66,122	3,202,075	$70,541,712
PHVS	Pharvaris N.V.	+61,369	1,201,402	$33,939,606
PCVX	Vaxcyte, Inc.	+25,592	824,532	$47,913,554
MNPR	Monopar Therapeutics	+19,925	345,626	$18,936,848
IKT	Inhibikase Therapeutics, Inc.	+6,646	3,863,445	$6,490,587
No positions match the current search.

Trimmed

Positions the filer reduced

6 positions

Ticker	Company	Δ Shares	Shares	Value
DYN	Dyne Therapeutics, Inc.	−822,007	966,609	$17,524,621
COGT	Cogent Biosciences, Inc.	−590,429	626,635	$24,119,181
AMLX	Amylyx Pharmaceuticals, Inc.	−146,602	4,349,885	$60,463,401
ABVX	Abivax S.A.	−106,483	542,696	$60,429,199
JAZZ	Jazz Pharmaceuticals plc	−85,109	162,961	$30,807,777
CELC	Celcuity Inc.	−35,191	281,904	$32,176,522
No positions match the current search.

New Positions

Positions the filer opened this quarter

4 positions

Ticker	Company	Shares	Value
CADL	Candel Therapeutics, Inc.	2,896,588	$14,193,281
ZURA	Zura Bio Ltd	739,960	$4,402,762
ANRO	Alto Neuroscience, Inc.	88,999	$2,000,697
MSLE	Satellos Bioscience Inc.	350,000	$1,970,500
No positions match the current search.

Sold Out

Positions the filer fully exited

3 positions

Ticker	Company	Shares	Value
OCUL	Ocular Therapeutix, Inc	1,504,880	$18,269,243
CNTA	Centessa Pharmaceuticals plc	282,692	$7,070,126
IVA	Inventiva S.A.	283,166	$1,316,721
No positions match the current search.

Portfolio Positions

Compact Export CSV View 13F filing

21 positions · $552,217,503 total · as of Mar 31, 2026

All sectors Healthcare

Ticker	Company	Type	Shares	Δ Shares	Value (USD)	% Δ Value	% of Portfolio
ALMS	Alumis Inc. Healthcare	Added	3,202,075	+66,122	$70,541,712	+130.5%	12.77%
AMLX	Amylyx Pharmaceuticals, Inc. Healthcare	Reduced	4,349,885	-146,602	$60,463,401	+11.3%	10.95%
ABVX	Abivax S.A. Healthcare	Reduced	542,696	-106,483	$60,429,199	−31.0%	10.94%
PCVX	Vaxcyte, Inc. Healthcare	Added	824,532	+25,592	$47,913,554	+30.0%	8.68%
PHVS	Pharvaris N.V. Healthcare	Added	1,201,402	+61,369	$33,939,606	+7.3%	6.15%
IMMX	Immix Biopharma, Inc. Healthcare	Added	3,693,585	+694,416	$33,648,559	+114.5%	6.09%
CELC	Celcuity Inc. Healthcare	Reduced	281,904	-35,191	$32,176,522	+1.7%	5.83%
JAZZ	Jazz Pharmaceuticals plc Healthcare	Reduced	162,961	-85,109	$30,807,777	−26.9%	5.58%
IRON	Disc Medicine, Inc. Healthcare	Added	449,926	+151,497	$28,768,268	+21.4%	5.21%
XFOR	X4 Pharmaceuticals, Inc Healthcare	Added	6,456,646	+656,116	$26,665,947	+14.9%	4.83%
COGT	Cogent Biosciences, Inc. Healthcare	Reduced	626,635	-590,429	$24,119,181	−44.2%	4.37%
MNPR	Monopar Therapeutics Healthcare	Added	345,626	+19,925	$18,936,848	−11.0%	3.43%
DYN	Dyne Therapeutics, Inc. Healthcare	Reduced	966,609	-822,007	$17,524,621	−49.9%	3.17%
IVVD	Invivyd, Inc. Healthcare	Added	10,949,084	+3,213,698	$14,233,809	−25.5%	2.58%
CADL	Candel Therapeutics, Inc. Healthcare	NEW	2,896,588	NEW	$14,193,281	NEW	2.57%
OCS	Oculis Holding AG Healthcare	Held	516,761	0	$13,740,674	+33.1%	2.49%
OVID	Ovid Therapeutics Inc. Healthcare	Added	4,166,666	+1,666,666	$9,249,998	+127.0%	1.68%
IKT	Inhibikase Therapeutics, Inc. Healthcare	Added	3,863,445	+6,646	$6,490,587	−17.9%	1.18%
ZURA	Zura Bio Ltd Healthcare	NEW	739,960	NEW	$4,402,762	NEW	0.80%
ANRO	Alto Neuroscience, Inc. Healthcare	NEW	88,999	NEW	$2,000,697	NEW	0.36%
MSLE	Satellos Bioscience Inc. Healthcare	NEW	350,000	NEW	$1,970,500	NEW	0.36%